Juan M. Li
State Key Laboratory Of Natural And Biomimetic Drugs
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Predictive Value of Patient-Derived Tumor Cell Cluster-Based Drug Sensitivity Assay in Advanced NSCLC.
Journal: Clinical Medicine Insights. Oncology
Published: August 09, 2025
Carboxyamidotriazole Regulates the Function of Salivary Gland Epithelial Cells and B Cells to Alleviate Experimental Sjögren's Disease in Mice.
Journal: International journal of medical sciences
Published: February 10, 2025
Treatment strategies for advanced neuroendocrine neoplasms: current status and future prospects.
Journal: Cancer biology & medicine
Published: January 03, 2025
A progression risk assessment model for pulmonary ground-glass nodules based on traditional Chinese medicine clinical symptoms combined with imaging.
Journal: Journal of integrative medicine
Published: December 11, 2024
Carboxyaminotriazole: A bone savior in collagen-induced arthritis-Halting osteoclastogenesis via interleukin-1β downregulation.
Journal: Life sciences
Published: November 13, 2024
Lung-intestinal axis, Shuangshen granules attenuate lung metastasis by regulating the intestinal microbiota and related metabolites.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 21, 2024
Genetically Predicted Plasma Levels of Amino Acids and Endometriosis: A Mendelian Randomization Study.
Journal: Biomedical and environmental sciences : BES
Published: January 01, 2024
TRIM34 suppresses non-small-cell lung carcinoma via inducing mTORC1-dependent glucose utilization and promoting cellular death.
Journal: Archives of biochemistry and biophysics
Published: July 23, 2023
Efficiency and toxicity of nab-paclitaxel and camrelizumab in the second or above line treatment of advanced non-small cell lung cancer: a retrospective cohort study.
Journal: Journal of thoracic disease
Published: December 28, 2022
AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
Journal: Clinical rheumatology
Published: February 01, 2022
Last Updated: 09/26/2026